Work

The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease

Year: 2016

Type: article

Source: Neurobiology of Disease

DOI: 10.1016/j.nbd.2016.10.006

Authors: Daniel Ryskamp, Jun Wu, Michal Geva, Rebecca Kusko, Iris Grossman, Michael Hayden, Ilya Bezprozvanny

Institutions: The University of Texas Southwestern Medical Center, Teva Pharmaceuticals (Israel), Immuneering (United States)

Language: English

Topic: Genetic Neurodegenerative Diseases

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Teva Pharmaceutical Industries, National Institutes of Health, National Institute of Neurological Disorders and Stroke

Awards: Calcium channels as novel therapeutic targets for Huntingtons Disease, G2443883458, G4693276466, G5658486318, G9000016908, G9000348813

OpenAlex ID: W2547401413

FWCI: 6.193

Cites: 104

Cited by: 131

Related to: 10